• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceSILIKON 1000
Generic NameFluid, intraocular
Regulation Number886.4275
ApplicantAlcon
6201 S. Freeway
Mail Drop R7-14
Fort Worth, TX 76134-2099
PMA NumberP950008
Date Received02/22/1995
Decision Date09/25/1997
Product Code LWL 
Docket Number 97M-0521
Notice Date 09/30/1997
Advisory Committee Ophthalmic
Expedited Review Granted? Yes
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for the SILIKON 1000. This device is indicated for use as a prolonged retinal tamponade in selected cases of complicated retinal detachments where other interventions are not appropriate for patient management. Complicated retinal detachments or recurrent retinal detachments occur most commonly in eyes with proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy (PDR), cytomegalovirus (CMV) retinitis, giant tears, and following perofrating injuries. SILIKON 1000 is also indicated for primary use in detachments due to AIDS) related CMV retinitis and other viral infections affecting the retina.
Supplements: S012 S006  S002 S008 S007 S009 S001 S004 S011 S010 S003 
S013 S016 S017 S021 S023 S014 S015 S018 S019 S022 
-
-